In a study of six tumor samples from five CCHD patients, including five sympathetic PPGLs and one carotid body paraganglioma (CB-PGL), we found that four out of five sympathetic PPGLs displayed a somatic EPAS1 mutation affecting either alanine 530 or proline 531 [75]. The gene discussed is EPAS1; the disease is neoplasm.